rs16835270

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000366574.7(RYR2):​c.1519G>A​(p.Val507Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00264 in 1,611,154 control chromosomes in the GnomAD database, including 107 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 57 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 50 hom. )

Consequence

RYR2
ENST00000366574.7 missense

Scores

5
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 4.07
Variant links:
Genes affected
RYR2 (HGNC:10484): (ryanodine receptor 2) This gene encodes a ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. The encoded protein is one of the components of a calcium channel, composed of a tetramer of the ryanodine receptor proteins and a tetramer of FK506 binding protein 1B proteins, that supplies calcium to cardiac muscle. Mutations in this gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), RYR2. . Gene score misZ 5.7809 (greater than the threshold 3.09). Trascript score misZ 6.4158 (greater than threshold 3.09). GenCC has associacion of gene with hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, catecholaminergic polymorphic ventricular tachycardia 1, arrhythmogenic right ventricular dysplasia 2, catecholaminergic polymorphic ventricular tachycardia.
BP4
Computational evidence support a benign effect (MetaRNN=0.008176357).
BP6
Variant 1-237456642-G-A is Benign according to our data. Variant chr1-237456642-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 43750.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-237456642-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0136 (2068/151800) while in subpopulation AFR AF= 0.0468 (1936/41344). AF 95% confidence interval is 0.0451. There are 57 homozygotes in gnomad4. There are 967 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2068 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RYR2NM_001035.3 linkuse as main transcriptc.1519G>A p.Val507Ile missense_variant 16/105 ENST00000366574.7 NP_001026.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RYR2ENST00000366574.7 linkuse as main transcriptc.1519G>A p.Val507Ile missense_variant 16/1051 NM_001035.3 ENSP00000355533 P1Q92736-1
RYR2ENST00000660292.2 linkuse as main transcriptc.1519G>A p.Val507Ile missense_variant 16/106 ENSP00000499787
RYR2ENST00000659194.3 linkuse as main transcriptc.1519G>A p.Val507Ile missense_variant 16/105 ENSP00000499653
RYR2ENST00000609119.2 linkuse as main transcriptc.1519G>A p.Val507Ile missense_variant, NMD_transcript_variant 16/1045 ENSP00000499659

Frequencies

GnomAD3 genomes
AF:
0.0137
AC:
2072
AN:
151688
Hom.:
57
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0470
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00532
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000387
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000368
Gnomad OTH
AF:
0.00861
GnomAD3 exomes
AF:
0.00362
AC:
896
AN:
247782
Hom.:
26
AF XY:
0.00297
AC XY:
399
AN XY:
134438
show subpopulations
Gnomad AFR exome
AF:
0.0470
Gnomad AMR exome
AF:
0.00242
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000559
Gnomad SAS exome
AF:
0.00125
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000312
Gnomad OTH exome
AF:
0.00233
GnomAD4 exome
AF:
0.00150
AC:
2188
AN:
1459354
Hom.:
50
Cov.:
39
AF XY:
0.00137
AC XY:
993
AN XY:
725906
show subpopulations
Gnomad4 AFR exome
AF:
0.0452
Gnomad4 AMR exome
AF:
0.00276
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00163
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000191
Gnomad4 OTH exome
AF:
0.00305
GnomAD4 genome
AF:
0.0136
AC:
2068
AN:
151800
Hom.:
57
Cov.:
33
AF XY:
0.0130
AC XY:
967
AN XY:
74160
show subpopulations
Gnomad4 AFR
AF:
0.0468
Gnomad4 AMR
AF:
0.00531
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000388
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000368
Gnomad4 OTH
AF:
0.00852
Alfa
AF:
0.00260
Hom.:
18
Bravo
AF:
0.0152
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0356
AC:
138
ESP6500EA
AF:
0.000362
AC:
3
ExAC
AF:
0.00420
AC:
508
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.000275
EpiControl
AF:
0.000179

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 10, 2012Val507Ile in exon 16 of RYR2: This variant is not expected to have clinical sign ificance because it has been identified in 3.5% (112/3188) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS/; dbSNP rs16835270) -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 16, 2023- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Catecholaminergic polymorphic ventricular tachycardia Benign:2
Likely benign, no assertion criteria providedclinical testingCohesion PhenomicsSep 23, 2022- -
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthOct 01, 2024- -
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 05, 2018This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 15, 2018- -
Arrhythmogenic right ventricular dysplasia 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 05, 2018This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 08, 2014This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
15
DANN
Benign
0.86
DEOGEN2
Uncertain
0.53
D;T
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.25
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.85
D;D
MetaRNN
Benign
0.0082
T;T
MetaSVM
Uncertain
-0.23
T
MutationAssessor
Benign
0.86
L;.
MutationTaster
Benign
0.60
N
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-0.47
N;.
REVEL
Uncertain
0.41
Sift
Benign
0.44
T;.
Polyphen
0.92
P;.
Vest4
0.13
MVP
0.79
MPC
0.75
ClinPred
0.037
T
GERP RS
2.7
Varity_R
0.074
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs16835270; hg19: chr1-237619942; COSMIC: COSV63684585; API